New Stock News | The IPO prospectus of Yanmei Biotech in Hong Kong has expired.

According to the China Securities and Finance App, the Hong Kong IPO prospectus submitted by Oriental Yanmei (Chengdu) Biotechnology Co., Ltd. (referred to as Yanmei Biotechnology) on May 12 expired on November 12 after being valid for 6 months, with Citi International serving as its exclusive sponsor.